[ad_1] As of today, psychedelics biotech Mind Medicine (MindMed) Inc. MNMD will trade its common shares based on a 1-for-15 reverse share split, the company announced on Friday. The company executed…
[ad_1] Ongoing discussions on whether psychedelics can help treat mental health conditions and improve quality of life have compelled officials and researchers to seek public opinion. All psychedelics are listed as Schedule…
[ad_1] Psychiatrists differ considerably in their perceptions of certain psychedelic substances. That’s according to a new report from Ohio State University, in which 181 doctors took part in a survey…
[ad_1] The DEA recently abandoned a proposal for placing five tryptamines as Schedule I under the Controlled Substances Act. Yet the agency is pushing forward to veto two psychedelic drugs named…
[ad_1] Biotech psychedelics company HAVN Life Sciences Inc. HAVLF recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July 21,…
[ad_1] In the face of the national -and worldwide- mental health crisis, the Thailand National Narcotics Control Board recently announced it will commence developing therapeutics extracted from or based on…
[ad_1] Publicly traded psychedelics company Psycheceutical Bioscience Inc. BWVI is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake. The company develops cutting-edge…
[ad_1] Awakn Life Sciences Corp. AWKNF, the biotech company focused on addiction treatments, has signed a licensing partnership agreement with US ketamine therapy clinics owner Revitalist Lifestyle and Wellness Ltd.…
[ad_1] Clinical-stage psychedelics company ATAI Life Sciences N.V. ATAI announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility agreement for up…
[ad_1] Short-acting psychedelics company Small Pharma Inc. DMTTF has received the approval from the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) and the Regional Ethics Committee for a drug…
[ad_1] Cybin Inc. CYBN CYBN has launched an at-the-market (ATM) equity program through which it will issue and sell up to $35 million in common shares in the company’s capital, from the…
[ad_1] Terran Biosciences Inc. is suing COMPASS Pathways CMPS for the appropriation of trade secrets. Terran, a private biotech platform company filed a complaint against COMPASS last Friday. On Monday, August 8,…
[ad_1] As interest in psychedelics grows, the non-profit initiative titled Microdosing Collective has been launched to promote the regulated uses of psychedelics, supporting education around regulations to allow for legal,…
[ad_1] Red Light Holland Corp. TRUFF, the Ontario-based company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America as well as…
[ad_1] San Francisco lawmakers in California recently introduced a resolution aiming at locally deprioritizing law enforcement on the possession, use, cultivation and social sharing of naturally-occurring psychedelic substances like psilocybin,…
[ad_1] House Reps. Alexandria Ocasio-Cortez (D-N.Y.) and Dan Crenshaw (R-Texas) have recently filed separate bills towards further advancing psychedelic research studies to active service members. While it was AOC’s proposal which…
[ad_1] Plant-based medicine producer Irwin Naturals Inc. IWINF has purchased all the assets of New England Ketamine located in Salem, New Hampshire and serving patients in six states in the…
[ad_1] As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedelic studies is remarkable. The agency annually invests about $41.7…
[ad_1] On July 20, bipartisan lawmakers from both chambers of Congress sent companion bills clarifying that federal Right to Try (RTT) laws give terminally-ill patients access to Schedule I substances including marijuana and…
[ad_1] Best-selling journalist and author Michael Pollan appeared live at The Late Show with Stephen Colbert on Thursday, on the heels of the Netflix release of How To Change Your Mind. “I…
[ad_1] The Centers for Disease Control and Prevention (CDC) recently launched a report on the U.S. unintentional overdose deaths in 25 states and the Columbia district. Rates were examined by race…
[ad_1] Biotech psychedelics company Awakn Life Sciences Corp. AWKNF has been granted funding for 66% of the costs from its phase 3 clinical trial on ketamine therapy for alcohol use disorder…
[ad_1] Biotech psychedelics company Awakn Life Sciences Corp. AWKNF has just published its business and corporate updates. Besides researching, developing and commercializing therapeutics to treat substance and behavioral addictions, Awakn’s near-term…
[ad_1] MAPS, an NGO leading research in the psychedelics space, is launching “Psychedelic Fundamentals,” an online psychedelic education program providing “accurate, evidence-based information on psychedelics,” now available for purchase on the organization’s website.…